Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
Praveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, Vanshika Singh, Hilal Ahmad Parray, Swarandeep Singh, Adarsh Kumar Chiranjivi, Ramachandran Thiruvengadam, Savita Singh, Naveen Yadav, Kamini Jakhar, Sudipta Sonar, Shailendra Mani, Sankar Bhattacharyya, Chandresh Sharma, Preeti Vishwakarma, Ritika Khatri, Anil Kumar Panchal, Supratik Das, Shubbir Ahmed, Sweety Samal, Pallavi Kshetrapal, Shinjini Bhatnagar, Kalpana Luthra, Rajesh Kumar
Topics & Concepts
VirologyAntibodyEpitopeAntibody-dependent cell-mediated cytotoxicityBiologyOriginal antigenic sinCross-reactivityNeutralizationImmune systemVirusNeutralizing antibodyInfluenza A virusGlycanImmunologyAntigenic driftMonoclonal antibodyGlycoproteinMolecular biologyCross reactionsSARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesRespiratory viral infections research